AXON (NASDAQ: AXON) Form 144 shows insider-linked 10,000-share sale notice

Rhea-AI Filing Summary

AXON submitted a Form 144 notice reporting the sale of 10,000 common shares tied to an option exercise dated 11/15/2021. The filing shows shares outstanding were 80,397,675 as of 02/25/2026. The excerpt also lists two recent sales by Patrick W. Smith: 10,000 shares on 12/08/2025 for $5,519,164 and 10,000 shares on 01/07/2026 for $6,190,146.

Insights

Capital Markets Attorney

Form 144 notifies the market of an intended resale of 10,000 common shares following an option exercise.

The filing lists a 10,000-share sale tied to an option exercise dated 11/15/2021, which is the operative transaction being reported. Rule 144 notices are a compliance step for restricted or control securities prior to resale.

Examples shown include two prior sales by Patrick W. Smith of 10,000 shares each on 12/08/2025 and 01/07/2026 with the dollar amounts shown. Timing and broker/dealer placement details are not provided in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	10000	5002400.00	80397675	02/25/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/15/2021	Option Exercise	Issuer			10000	11/15/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Patrick W. Smith 17800 N. 85th ST. Scottsdale AZ 85255	Common	12/08/2025	10000	5519164.00
Patrick W. Smith 17800 N. 85th ST. Scottsdale AZ 85255	Common	01/07/2026	10000	6190146.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AXON's Form 144 report say about the shares being sold?

It reports the resale of 10,000 common shares tied to an option exercise dated 11/15/2021. The notice lists the transaction type as an option exercise and indicates cash proceeds as the sale method.

Who executed recent share sales related to AXON in the filing?

Patrick W. Smith is shown executing two recent sales of 10,000 shares each. The sales occurred on 12/08/2025 and 01/07/2026 with the dollar amounts provided in the excerpt.

How many AXON shares were outstanding as noted in the excerpt?

The excerpt lists shares outstanding as 80,397,675 as of 02/25/2026. This figure appears on the filing cover data and serves as a baseline context within the provided content.

Does the Form 144 specify who will receive proceeds from the sale?

The excerpt indicates the sale method as cash but does not specify who will receive proceeds. The filing entry lists 'Cash' as the sale type but does not name the payee or intended use of proceeds.

Is the Form 144 itself a confirmation that shares were sold?

No; a Form 144 is a notice that permits resale under Rule 144, not proof of execution. The filing signals intent or planned resale; execution and settlement details are not contained in the excerpt.